INDSWIFT LABORATORIES
Quarterly Results Analysis [Dec2024]
INDSWIFT LABORATORIES Quarterly Results
Consolidated | Dec2024 UnAudited |
Sep2024 UnAudited |
Jun2024 UnAudited |
Mar2024 UnAudited |
Dec2023 UnAudited |
Sep2023 Audited |
Jun2023 UnAudited |
Mar2023 Audited |
---|---|---|---|---|---|---|---|---|
Revenues | ₹9 Cr | ₹12 Cr | ₹33 Cr | ₹393 Cr | ₹288 Cr | ₹290 Cr | ₹310 Cr | ₹304 Cr |
Expenses | ₹23 Cr | ₹24 Cr | ₹43 Cr | ₹431 Cr | ₹236 Cr | ₹224 Cr | ₹250 Cr | ₹241 Cr |
Operating Income | ₹-15 Cr | ₹-12 Cr | ₹-10 Cr | ₹-37 Cr | ₹52 Cr | ₹66 Cr | ₹60 Cr | ₹64 Cr |
Other Income | ₹14 Cr | ₹13 Cr | ₹11 Cr | ₹25 Cr | ₹7 Cr | ₹7 Cr | ₹6 Cr | ₹10 Cr |
Interest | ₹0 Cr | ₹0 Cr | ₹0 Cr | ₹-11 Cr | ₹21 Cr | ₹21 Cr | ₹20 Cr | ₹22 Cr |
Depreciation | ₹0 Cr | ₹0 Cr | ₹0 Cr | ₹13 Cr | ₹14 Cr | ₹13 Cr | ₹14 Cr | ₹9 Cr |
Profit Before Tax | ₹-1 Cr | ₹1 Cr | ₹1 Cr | ₹373 Cr | ₹24 Cr | ₹39 Cr | ₹32 Cr | ₹16 Cr |
Profit After Tax | ₹0 Cr | ₹0 Cr | ₹1 Cr | ₹239 Cr | ₹20 Cr | ₹32 Cr | ₹17 Cr | ₹-25 Cr |
EPS | ₹0.00 | ₹0.07 | ₹0.16 | ₹40.42 | ₹3.29 | ₹5.36 | ₹2.92 | ₹-4.25 |
Industry Peers & Returns | 1W | 1M | 1Y |
INDSWIFT LABORATORIES | 2.4% | -3.2% | -32.9% |
SUN PHARMACEUTICAL INDUSTRIES | 3.4% | 2.2% | 13.6% |
DIVIS LABORATORIES | 5.3% | 3.9% | 51.8% |
CIPLA | 3.3% | 1.2% | 9.7% |
TORRENT PHARMACEUTICALS | 4% | 6.3% | 29.2% |
DR REDDYS LABORATORIES | 6.1% | 2.3% | -3.2% |
MANKIND PHARMA | 9.9% | 18.9% | 14% |
ZYDUS LIFESCIENCES | -2.7% | -5.4% | -11.1% |
LUPIN | 2% | 0.9% | 20.4% |
INDSWIFT LABORATORIES Quarterly Revenues
Revenues | |
---|---|
Q-o-Q | -27.53 % |
Y-o-Y | -96.99 % |
Quarters | Revenues | % Change | |
---|---|---|---|
Dec2024 | ₹9 Cr | -27.53 | |
Sep2024 | ₹12 Cr | -63.95 | |
Jun2024 | ₹33 Cr | -91.57 | |
Mar2024 | ₹393 Cr | 36.81 | |
Dec2023 | ₹288 Cr | -0.76 | |
Sep2023 | ₹290 Cr | -6.65 | |
Jun2023 | ₹310 Cr | 2.00 | |
Mar2023 | ₹304 Cr | - |
INDSWIFT LABORATORIES Quarterly Operating Profit
Operating Profit | |
---|---|
Q-o-Q | Negative |
Y-o-Y | Negative |
Quarters | Operating Profit | % Change | |
---|---|---|---|
Dec2024 | ₹-15 Cr | Negative | |
Sep2024 | ₹-12 Cr | Negative | |
Jun2024 | ₹-10 Cr | Negative | |
Mar2024 | ₹-37 Cr | Negative | |
Dec2023 | ₹52 Cr | -21.32 | |
Sep2023 | ₹66 Cr | 8.95 | |
Jun2023 | ₹60 Cr | -5.30 | |
Mar2023 | ₹64 Cr | - |
Operating Margins | |
---|---|
Q-o-Q | Negative |
Y-o-Y | Negative |
Quarters | Operating Margin% | % Change | |
---|---|---|---|
Dec2024 | -167.71% | Negative | |
Sep2024 | -98.65% | Negative | |
Jun2024 | -29.37% | Negative | |
Mar2024 | -9.48% | Negative | |
Dec2023 | 17.98% | -20.72 | |
Sep2023 | 22.68% | 16.73 | |
Jun2023 | 19.43% | -7.17 | |
Mar2023 | 20.93% | - |
INDSWIFT LABORATORIES Quarterly Profit After Tax
Profit After Tax(PAT) | |
---|---|
Q-o-Q | Negative |
Y-o-Y | Negative |
Quarters | Profit After Tax | % Change | |
---|---|---|---|
Dec2024 | ₹0 Cr | Negative | |
Sep2024 | ₹0 Cr | -60.46 | |
Jun2024 | ₹1 Cr | -99.58 | |
Mar2024 | ₹239 Cr | 1,123.16 | |
Dec2023 | ₹20 Cr | -38.65 | |
Sep2023 | ₹32 Cr | 82.97 | |
Jun2023 | ₹17 Cr | Positive | |
Mar2023 | ₹-25 Cr | - |
PAT Margins | |
---|---|
Q-o-Q | Negative |
Y-o-Y | Negative |
Quarters | PAT Margin(%) | % Change | |
---|---|---|---|
Dec2024 | -0.05 % | Negative | |
Sep2024 | 3.34 % | 9.87 | |
Jun2024 | 3.04 % | -94.99 | |
Mar2024 | 60.73 % | 794.40 | |
Dec2023 | 6.79 % | -38.22 | |
Sep2023 | 10.99 % | 95.90 | |
Jun2023 | 5.61 % | Positive | |
Mar2023 | -8.23 % | - |
INDSWIFT LABORATORIES Quarterly Earnings Per Share (EPS)
EPS | |
---|---|
Q-o-Q | -100.00 % |
Y-o-Y | -100.00 % |
Quarters | EPS | % Change | |
---|---|---|---|
Dec2024 | ₹0 | -100.00 | |
Sep2024 | ₹0.07 | -56.25 | |
Jun2024 | ₹0.16 | -99.60 | |
Mar2024 | ₹40.42 | 1,128.57 | |
Dec2023 | ₹3.29 | -38.62 | |
Sep2023 | ₹5.36 | 83.56 | |
Jun2023 | ₹2.92 | Positive | |
Mar2023 | ₹-4.25 | - |
You may also like the below Video Courses
SUN PHARMACEUTICAL INDUSTRIES LTD vs DIVIS LABORATORIES LTD vs CIPLA LTD
TORRENT PHARMACEUTICALS LTD vs DR REDDYS LABORATORIES LTD vs MANKIND PHARMA LTD